Queens Library Healthlink Initiative Launched
The Queens Library HealthLink initiative was developed to place libraries at the center of an innovative new effort designed to help medically underserved communities throughout Queens access free cancer information, early detection screenings, cancer treatment resources, and other life-saving services.
An Interview with Alan Hall
Alan Hall, Chair of the Sloan-Kettering Institute's Cell Biology Program, discusses his far-ranging professional journey and explains his research objectives and program goals at Sloan-Kettering Institute.
Memorial Sloan-Kettering Transplant Survivors Celebrate Life at 11th Annual Party
More than 400 guests gathered in the Rockefeller Research Laboratories on October 26 for the 11th annual Stem Cell Transplant Survivors Celebration.
New Standard of Care Recommended for Advanced Kidney Cancer
Newly published results from a randomized, Phase III trial led by Memorial Sloan-Kettering investigators show that the drug sunitinib malate (Sutent®) is more effective than the conventional treatment given as an initial therapy for patients with advanced kidney cancer.
T Cell Precursors Improve Immune Response After Bone Marrow Transplantation
A study led by immunologist and Adult Bone Marrow Transplant Service Chief Marcel R. van den Brink has demonstrated a novel strategy for boosting numbers of infection-fighting T cells in mice after allogeneic bone marrow transplantation.
Novel Regulation of the Common Tumor Suppressor PTEN
Researchers led by scientists at Memorial Sloan-Kettering Cancer Center have now identified fundamentally novel regulatory mechanisms of PTEN function. The findings from two related studies are published in the January 12 issue of Cell.
